Clinical study of prostate cancer dagnositic makers using genetic polymorphisms

Clinical study of prostate cancer dagnositic makers using genetic polymorphisms - Prostate cancer and genetic polymorphism

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019278

Enrollment

2000

Registered

2015-10-08

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who reveive prostate biopsy for the diagnosis of prostate cancer. Pathens who got the concent for the study.

Exclusion criteria

Exclusion criteria: Patients who got prostate biopsy previously. Patients harboring other cancers or receiving the treatment for other cancers.

Design outcomes

Primary

Measure	Time frame
The utility of prostate cancer risk scores for the detection of prostate cance by prostate biopsy	—

Secondary

Measure	Time frame
The association of prostate cancer risk scores and the aggressiveness or prognsosis of prostate cancer	—

Countries

Japan

Contacts

Public ContactNaoki Terada

Kyoto University Graduate School of Medicine Department of Urology

nterada@kuhp.kyoto-u.ac.jp075-751-3337

Outcome results